The objective of this guideline is to provide clinical practice recommendations for the use of biodegradable spacers for prostate cancer treatment.
Patients undergoing radiation treatment for localized prostate cancer
Intended Guideline Users
Radiation oncologists and genitourinary oncologists involved in the management of prostate cancer.
Does the use of biodegradable hydrogel spacers during RT for prostate cancer decrease rectal (and other) toxicities and maintain QOL following treatment